Reference: | [1]. Ma, Zonghui et al. “Drug Discovery Targeting Nuclear Receptor Binding SET Domain Protein 2 (NSD2).” Journal of medicinal chemistry vol. 66,16 (2023): 10991-11026. doi:10.1021/acs.jmedchem.3c00948
[2].Deng, Haibing; Liu, Jinbiao; Oyang, Counde; Wang, Ce; Xiao, Qitao; Xun, Guoliang; Zeng, Haiqiang. Piperidinyl-methyl-purinamines as NSD2 inhibitors and anti-cancer agents and their preparation. WO2021028854 A1
[3]. He, Lin et al. “NSD family proteins: Rising stars as therapeutic targets.” Cell insight vol. 3,2 100151. 3 Feb. 2024, doi:10.1016/j.cellin.2024.100151
|
---|